The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
REGENXBIO
Rockville, United States
B
251-500 Employees
2009
Key takeaway
REGENXBIO is focused on advancing in vivo gene therapy through its innovative AAV gene therapies, aiming to provide one-time treatments for various diseases. Their commitment to research and development in this field highlights their role as pioneers in gene therapy.
Highlighted product
Core business
Pioneers in Gene Therapy
Be The Match BioTherapies
Minneapolis, United States
B
1001-5000 Employees
2016
Key takeaway
Be The Match BioTherapies is dedicated to providing comprehensive support for both allogeneic and autologous cell and gene therapy development. With over 35 years of experience, they empower the discovery, development, and delivery of next-generation therapies, ensuring that patients receive the critical treatments they need.
Highlighted product
Product
Cell and Gene Therapy Solutions | Be The Match BioTherapies
Be The Match BioTherapies helps you mitigate risk with allogeneic or autologous cell and gene therapy solutions that scale with you at every step.
Genezen Laboratories
Indianapolis, United States
B
1-10 Employees
2014
Key takeaway
Genezen is a specialized viral vector contract development and manufacturing organization (CDMO) that focuses on GMP manufacturing of lentiviral and retroviral vectors, which are critical for in vivo gene therapy applications. With a commitment to accelerating the development and commercialization of innovative therapies, Genezen offers extensive expertise and capacity in viral vector process development and manufacturing.
Highlighted product
Core business
Genezen | GMP Viral Vector Manufacturer | Viral Vector CDMO
Genezen is a US-based viral vector CDMO specializing in GMP viral vector manufacturing, viral vector development, cell manufacturing & testing
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Aldevron
Fargo, United States
B
101-250 Employees
1998
Key takeaway
Aldevron has extensive experience in advancing therapeutic development, providing high-quality plasmid DNA and other biologicals essential for in vivo gene therapy. Their focus on non-viral approaches and scalable mRNA manufacturing highlights their commitment to improving performance and safety in modern therapeutic applications.
Highlighted product
Product
Reviver and HyperGro
Expression Therapeutics
Tucker, United States
B
11-50 Employees
-
Key takeaway
Expression Therapeutics specializes in developing gene therapies for various conditions, including Hemophilia A and B, Neuroblastoma, and leukemia. Their advanced manufacturing facility supports the production of cGMP LV and AAV vectors, enhancing the development of their clinical programs.
Highlighted product
Core business
Expression Therapeutics
Jaguar Gene Therapy
Lake Forest, United States
B
11-50 Employees
2019
Key takeaway
Jaguar Gene Therapy is dedicated to accelerating breakthroughs in gene therapy for patients with severe genetic diseases. They are focused on developing transformative gene therapy solutions that can significantly impact the lives of those affected by these conditions.
Highlighted product
Core business
pexels-josh-hild-4606770 | Jaguar Gene Therapy
Alliance Regenerative Medicine
Washington, United States
B
11-50 Employees
2009
Key takeaway
The company highlights its focus on regenerative medicine, which encompasses gene therapies aimed at repairing and regenerating biological functions. This aligns with the advancements and opportunities in the in vivo gene therapy sector.
Highlighted product
Product
Gene-Based Medicine - Alliance for Regenerative Medicine
Interius BioTherapeutics
Philadelphia, United States
B
11-50 Employees
2019
Key takeaway
Interius is focused on advancing in vivo gene therapy by developing innovative methods to engineer cells directly within the human body. Their approach involves reengineering viral vectors to enhance the effectiveness of cell-specific therapies, particularly for diseases that current modalities cannot adequately address.
Highlighted product
Core business
Gene Therapy | In Vivo Cell Therapy | In Vivo Gene Therapy | Interius
Interius is a preclinical stage company expanding the potential of gene therapy by reengineering viral vectors to drive cell-specific therapy.
iECURE
Philadelphia, United States
B
- Employees
2012
Key takeaway
iECURE is dedicated to in vivo gene therapy, specifically focusing on gene editing for liver disorders in children. They are developing innovative approaches to treat conditions like ornithine transcarbamylase deficiency and phenylketonuria, emphasizing the potential of gene editing to address significant patient needs.
Highlighted product
Core business
Home | iECURE
Knocking down devastation. Inserting hope. At iECURE, we believe in vivo gene editing is the answer to meeting this immense patient need, and we believe reversing the course of these conditions is now within reach.
American Gene Technologies International
Rockville, United States
B
11-50 Employees
2007
Key takeaway
American Gene Technologies is dedicated to developing gene and cell therapies, particularly for monogenic disorders and cancers. Their innovative approach includes a Phase 1 trial of AGT103-T, a modified T cell therapy that offers promise for a functional cure for HIV.
Highlighted product
Core business
Addimmune: Advancing a Cure for HIV Through Gene Therapy
Imagine a world without HIV. Addimmune's gene therapy technology is helping make that a reality.
Technologies which have been searched by others and may be interesting for you:
When exploring the in vivo gene therapy industry in the United States, several key considerations come into play. Regulatory compliance is paramount, as the Food and Drug Administration (FDA) oversees the approval processes for gene therapies. Companies must navigate complex clinical trial phases while adhering to stringent safety and efficacy requirements. The competitive landscape is rapidly evolving, with numerous biotech firms and research institutions developing innovative therapies, thus presenting both opportunities and challenges. Funding is another critical factor; significant investment is often required for research and development, and partnerships with pharmaceutical companies can provide necessary resources. Additionally, it's essential to stay informed about the latest scientific advancements and technological innovations that drive this field. Environmental concerns, particularly regarding the long-term effects of gene therapies, are increasingly relevant, prompting discussions about ethical implications and ecological impacts. The global market for gene therapy is expanding, with the U.S. being a leader in this sector. Understanding the international regulatory environment and market dynamics can provide insights into potential collaborations or competition. Overall, thorough research into these factors will help individuals and organizations make informed decisions in the in vivo gene therapy landscape.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 2580 |
| Amount of suitable service providers | 1672 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1998 |
| Youngest suiting company | 2019 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Biotechnology, Other, Healthcare, Medical, Pharmaceuticals
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
